Advanced search
1 file | 273.97 KB

End-of-life decision-making across cancer types : results from a nationwide retrospective survey among treating physicians

(2018) BRITISH JOURNAL OF CANCER. 118. p.1369-1376
Author
Organization
Abstract
BACKGROUND: The treatment of advanced cancer often involves potentially life-shortening end-of-life decisions (ELDs). This study aimed to examine the prevalence and characteristics of ELDs in different cancer types. METHODS: A nationwide death certificate study was conducted based on a large random sample of all deaths in Flanders, Belgium, between 1 January and 30 June 2013. All cancer deaths were selected (n = 2392). Attending physicians were sent a questionnaire about ELDs and the preceding decision-making process. RESULTS: The response rate was 58.3%. Across cancer types, a non-treatment decision occurred in 7.6-14.0%, intensified pain and symptom alleviation in 37.5-41.7%, euthanasia or physician-assisted suicide in 8.7-12.6%, and life shortening without explicit patient request in 1.0-2.4%. ELD prevalence did not differ significantly by cancer type. Reasons for ELDs were most frequently patient's physical suffering and lack of prospect of improvement. 'Anticipated further suffering' and 'unbearable situation for relatives' were reasons more often reported in haematological cancer than in other cancer types. Patient, family, and caregiver involvement in decision-making did not differ across cancer types. CONCLUSIONS: Euthanasia or physician-assisted suicide rates were relatively high in all cancer types. Neither the prevalence of ELDs nor characteristics of the decision-making process differed substantially between cancer types. This indicates a uniform approach to end-of-life care, including palliative care, across oncological settings.
Keywords
PALLIATIVE CARE SERVICES, ASSISTED SUICIDE, NONCANCER PATIENTS, EUTHANASIA LAW, SYMPTOM BURDEN, RESPONSE RATES, BELGIUM, NETHERLANDS, OPIOIDS, ACCESS

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 273.97 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Verkissen, Mariëtte N, Dirk Houttekier, Joachim Cohen, Rik Schots, Kenneth Chambaere, and Luc Deliens. 2018. “End-of-life Decision-making Across Cancer Types : Results from a Nationwide Retrospective Survey Among Treating Physicians.” British Journal of Cancer 118: 1369–1376.
APA
Verkissen, M. N., Houttekier, D., Cohen, J., Schots, R., Chambaere, K., & Deliens, L. (2018). End-of-life decision-making across cancer types : results from a nationwide retrospective survey among treating physicians. BRITISH JOURNAL OF CANCER, 118, 1369–1376.
Vancouver
1.
Verkissen MN, Houttekier D, Cohen J, Schots R, Chambaere K, Deliens L. End-of-life decision-making across cancer types : results from a nationwide retrospective survey among treating physicians. BRITISH JOURNAL OF CANCER. 2018;118:1369–76.
MLA
Verkissen, Mariëtte N et al. “End-of-life Decision-making Across Cancer Types : Results from a Nationwide Retrospective Survey Among Treating Physicians.” BRITISH JOURNAL OF CANCER 118 (2018): 1369–1376. Print.
@article{8560776,
  abstract     = {BACKGROUND: The treatment of advanced cancer often involves potentially life-shortening end-of-life decisions (ELDs). This study aimed to examine the prevalence and characteristics of ELDs in different cancer types. 
METHODS: A nationwide death certificate study was conducted based on a large random sample of all deaths in Flanders, Belgium, between 1 January and 30 June 2013. All cancer deaths were selected (n = 2392). Attending physicians were sent a questionnaire about ELDs and the preceding decision-making process. 
RESULTS: The response rate was 58.3%. Across cancer types, a non-treatment decision occurred in 7.6-14.0%, intensified pain and symptom alleviation in 37.5-41.7%, euthanasia or physician-assisted suicide in 8.7-12.6%, and life shortening without explicit patient request in 1.0-2.4%. ELD prevalence did not differ significantly by cancer type. Reasons for ELDs were most frequently patient's physical suffering and lack of prospect of improvement. 'Anticipated further suffering' and 'unbearable situation for relatives' were reasons more often reported in haematological cancer than in other cancer types. Patient, family, and caregiver involvement in decision-making did not differ across cancer types. 
CONCLUSIONS: Euthanasia or physician-assisted suicide rates were relatively high in all cancer types. Neither the prevalence of ELDs nor characteristics of the decision-making process differed substantially between cancer types. This indicates a uniform approach to end-of-life care, including palliative care, across oncological settings.},
  author       = {Verkissen, Mariëtte N and Houttekier, Dirk and Cohen, Joachim and Schots, Rik and Chambaere, Kenneth and Deliens, Luc},
  issn         = {0007-0920},
  journal      = {BRITISH JOURNAL OF CANCER},
  keywords     = {PALLIATIVE CARE SERVICES,ASSISTED SUICIDE,NONCANCER PATIENTS,EUTHANASIA LAW,SYMPTOM BURDEN,RESPONSE RATES,BELGIUM,NETHERLANDS,OPIOIDS,ACCESS},
  language     = {eng},
  pages        = {1369--1376},
  title        = {End-of-life decision-making across cancer types : results from a nationwide retrospective survey among treating physicians},
  url          = {http://dx.doi.org/10.1038/s41416-018-0070-5},
  volume       = {118},
  year         = {2018},
}

Altmetric
View in Altmetric
Web of Science
Times cited: